Table of contents

Electronic pages

• Autoantibodies and interstitial lung disease in rheumatoid arthritis: towards a ‘mix-and-match’ approach? (2 April, 2020) Free

  Alessia Alunno, Onelia Bistoni, Angelo Francesco Bonifacio, Roberto Gerli
• Response to: ‘Autoantibodies and interstitial lung disease in rheumatoid arthritis: towards a ‘mix-and-match’ approach’ by Alunno et al

  (28 May, 2020) Free

  Raul Castellanos-Moreira, Sebastian Cruz Rodríguez-García, Isabel Haro, Raimon Sanmarti
• Increasing the threshold for patient global assessment in defining remission may have a different impact in patients with early and established rheumatoid arthritis (20 April, 2020) Free

  Serena Bugatti, Ludovico De Stefano, Ennio Giulio Favalli, Roberto Caporali, Carlomaurizio Montecucco
• Response to: ‘Increasing the threshold for patient global assessment in defining remission may have a different impact in patients with early and established rheumatoid arthritis’ by Bugatti et al

  (12 May, 2020) Free

  Paul Studenic, David T Felson, Maarten de Wit, Josef S Smolen, Daniel Aletaha
• Withdrawal of low-dose prednisone in inactive SLE patients: Is there another alternative? (27 April, 2020) Free

  José Mario Sabio
• Response to: ‘Withdrawal of low-dose prednisone in inactive SLE patients: is there another alternative?’ by Sabio (7 May, 2020) Free

  Alexis Mathian, Micheline Pha, Zahir Amoura
• External validation of EULAR/ACR classification criteria for idiopathic inflammatory myopathies (12 May, 2020) Free

  Queenie Luu, Jessica Day, Alix Hall, Vidya Limaye, Gabor Major
• Response to: ‘External validation of EULAR/ACR classification criteria for idiopathic inflammatory myopathies’ by Luu et al

  (12 May, 2020) Free

  Masatoshi Jinnin, Akiko Ohta, Hitoshi Kohsaka
• Successful treatment of plasma exchange for refractory systemic juvenile idiopathic arthritis complicated with macrophage activation syndrome and severe lung disease (3 April, 2020) Free

  Satoshi Sato, Takahiro Hosokawa, Hisashi Kawashima
• Response to: ‘Successful treatment of plasma exchange for refractory systemic juvenile idiopathic arthritis complicated with macrophage activation syndrome and severe lung disease’ by Sato et al

  (21 April, 2020) Free

  Vivian E Saper, Guangbo Chen, R Paul Guillerman, Purvesh Khatri, Randy Q Cron, Elizabeth D Mellins
• Is non-industrial society undergoing an energy balance transition predisposed to accumulate abdominal adipose tissue and susceptible to knee osteoarthritis? (4 May, 2020) Free

  Yang Yu, Shitao Lu, Jianzhong Xu
• Response to: ‘Is non-industrial society undergoing an energy balance transition predisposed to accumulate abdominal adipose tissue and susceptible to knee osteoarthritis?’ by Yu et al

  (4 May, 2020) Free

  Ian J Wallace, David T Felson, Steven Worthington, Daniel E Lieberman
• Use of tanezumab for patients with hip and knee osteoarthritis with reference to a randomised clinical trial by Berenbaum and colleagues (22 April, 2020) Free

  Daniel Riddle, Robert Perera
• Response to: ‘Use of tanezumab for patients with hip and knee osteoarthritis with reference to a randomised clinical trial by Berenbaum and colleagues’ by Riddle and Perera (18 May, 2020) Free

  Francis Berenbaum, Francisco J Blanco, Ali Guermazi, Kenji Miki, Takaharu Yamabe, Lars Viktrup, Rod Junor, William Carey, Mark T Brown, Christine R West, Kenneth M Verburg
• JAK inhibitors as promising agents for refractory Takayasu arteritis (27 April, 2020) Free

  Ryu Watanabe
• Response to: ‘JAK inhibitors as promising agents for refractory Takayasu arteritis’ by Watanabe (7 May, 2020) Free

  Shun Tanimura, Hiroyuki Nakamura, Tetsuya Horita